Risperdal Consta Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Trial of the Efficacy and the Safety of RO6889450 vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
Condition:   Schizophrenia, Schizoaffective Disorder Interventions:   Drug: RO6889450;   Drug: Placebo;   Drug: Risperidone Sponsor:   Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 13, 2020 Category: Research Source Type: clinical trials